WBAL-TV4d
Judge denies change of venue for Victor Martinez-Hernandez charged in Rachel Morin's killing
A judge denies a defense motion for a change of venue in the case of the El Salvadorean national charged in the killing of Rachel Morin.
Yahoo Finance13d
Viralgen and Axovia partner to manufacture an investigational gene therapy for retinal dystrophy in Bardet-Biedl Syndrome (BBS) patients
Dr. Victor Hernandez. "Our lead program, AXV-101, which is being developed to address retinal dystrophy associated with Bardet-Biedl Syndrome (BBS) is expected to enter clinical development in mid ...
Pharmaceutical Technology12d
Viralgen and Axovia to develop gene therapy for retinal dystrophy
Axovia co-founder and chief scientific officer Dr Victor Hernandez stated: “As Axovia advances its pipeline of potential therapies addressing the genetic causes of blindness towards the clinic, we ...
Pharm Exec12d
Viralgen and Axovia Partner to Manufacture Gene Therapy for Retinal Dystrophy in Bardet-Biedl Syndrome Patients
we want to ensure we have appropriately scaled AAV manufacturing to support this effort and are very happy to have partnered with Viralgen as our CDMO," Axovia co-founder and chief scientific officer ...